Site Map
Posts
- Category: Wp Feeds (continued)
- Americans' Rx Drug Spending Tops $300 Billion
- An Update on Therapeutics for COVID-19
- Anal Cancer Rates Continue to Rise (CME/CE)
- Analysis in 150 Seconds: Diet and Colorectal Cancer Risk
- Andrew von Eschenbach and the Cancer Cure
- Anemia Top Side Effect of HCV Antivirals (CME/CE)
- Another Boost for Minimally Invasive Surgery (CME/CE)
- Another GERD Drug Goes Generic
- Another JAK1 Inhibitor Performs Well in Crohn's Disease (CME/CE)
- Another Record Year for Organ Transplants
- Antacids Don't Improve Pulmonary Fibrosis Outcomes (CME/CE)
- Anti-Hep B Tx Drives Changes in Liver Transplantation (CME/CE)
- Anti-IL-13 Shows Promise as EoE Treatment
- Anti-Vaxxer Gets 5 Years for Encouraging Terrorism During the Pandemic
- Antibiotic Cuts Death Risk in Severe Cirrhosis (CME/CE)
- Antibiotic Passes Test for Use in IBS (CME/CE)
- Antibiotic Resistance Not a New Phenomenon (CME/CE)
- Antibiotics for Appendicitis Has Its Downsides
- Antibiotics Tied to IBD in Kids (CME/CE)
- Antibiotics Tied to IBD in Kids (CME/CE)
- Antibiotics Tied to IBD in Kids (CME/CE)
- Antibiotics Tied to IBD in Kids (CME/CE)
- Antibiotics Up Risk for Colon Polyps (CME/CE)
- Antibody Mix Exhibits Antitumor Activity in Colon Ca (CME/CE)
- Antibody Test Spots IBS
- Antiemetic Use in Gastroenteritis Found to Cut Costs (CME/CE)
- Antihistamine Improves Quality of Sedation During Colonoscopy
- Antioxidant Aids Liver Graft Survival (CME/CE)
- Antiretroviral Tx Has Lukewarm Results in PBC (CME/CE)
- Antisense Drug Scores in Crohn's Disease (CME/CE)
- Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
- Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
- Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
- Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
- Antiviral Reduces HBV Transmission in Pregnancy (CME/CE)
- Antivirals Bust Risk of Cancer in HCV (CME/CE)
- Antivirals Bust Risk of Cancer in HCV (CME/CE)
- Any Screening for Colon Cancer Better Than None (CME/CE)
- Apatinib Shines in Gastric Cancer Trial (CME/CE)
- Apple Juice Tx Promising in Kids with Mild Gastroenteritis (CME/CE)
- Aprepitant Trial in Gastroparesis Misses the Primary Mark
- Arabian Knives: Working the OR in the Middle East
- Are Medicare ACOs Working? Experts Disagree
- Are New Colon Cancer Drugs Worth It? The Gastro and Endo News Report
- ASCO Calls for New Approaches in Cancer Research
- ASCO GI: Agent Shows Promise in Pancreatic Cancer
- ASCO GI: Biologic Helps in Esophageal Cancer (CME/CE)
- ASCO GI: Bone Drugs Cut CRC Risk
- ASCO GI: Chemo Delay Puts Lives at Risk in Colon CA (CME/CE)
- ASCO GI: Data from Adjuvant CRC Study Perplexing
